Sanofi files sBLA with FDA for intradermal influenza vaccine
Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs